IP Library Granted Patent US 11,248,282
Granted Patent B2
US 11,248,282 · App. 16/506,298 · Granted Feb 15, 2022

Magnesium alloy

Inventors: Hironori Ueda (Kumamoto, JP); Masashi Inoue (Kumamoto, JP); Makoto Sasaki (Kumamoto, JP)
Assignees: FUJI LIGHT METAL CO., LTD.; Japan Medical Device Technology Co., LTD.
C22C23/04A61L31/022
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,248,282
App. No.
16/506,298
Granted
Feb 15, 2022
Kind
B2
Abstract

Magnesium alloy containing, in % by mass, 1.0 to 2.0% of Zn, 0.05 to 0.80% by mass of Zr, 0.05 to 0.40% by mass of Mn, and the balance consisting of Mg and unavoidable impurities. The magnesium alloy may further contain, in % by mass, 0.005% or more and less than 0.20% of Ca.

Claims (10)

1. A magnesium alloy consisting of, in % by mass, 1.0 to 2.0% of Zn, 0.05 to 0.80% of Zr, 0.05 to 0.40% of Mn, and the balance consisting of Mg and unavoidable impurities, wherein the magnesium alloy consists of a matrix phase composed of single-phase solid solution and Zr-bearing precipitates dispersed in the matrix phase, wherein an amount of each of Fe, Ni, Co, and Cu as unavoidable impurities is less than 10 ppm, a total content of the unavoidable impurities is 30 ppm or less, and grain sizes of the precipitates are smaller than 500 nm.

2. A magnesium alloy consisting of, in % by mass, 1.0 to 2.0% of Zn, 0.05 to 0.80% of Zr, 0.05 to 0.40% of Mn, 0.005% to less than 0.20% of Ca, and the balance consisting of Mg and unavoidable impurities, wherein the magnesium alloy consists of matrix phase composed of single-phase solid solution and Zr-bearing precipitates dispersed in the matrix phase, wherein an amount of each of Fe, Ni, Co, and Cu as unavoidable impurities is less than 10 ppm, a total content of the unavoidable impurities is 30 ppm or less, and grain sizes of the precipitates are smaller than 500 nm.

3. The magnesium alloy according to claim 1 , wherein the magnesium alloy is free from rare earth elements and aluminum.

4. The magnesium alloy according to claim 1 , wherein an average grain size of the matrix phase is 1 to 10 μm.

5. The magnesium alloy according to claim 1 , having, in the values measured according to JIS Z2241, a tensile strength of 230 to 380 MPa, a proof stress of 180 to 330 MPa, a fracture elongation of 10 to 30%.

6. A medical device including a metal member comprising the magnesium alloy according to claim 1 .

7. The magnesium alloy according to claim 2 , wherein the magnesium alloy is free from rare earth elements and aluminum.

8. The magnesium alloy according to claim 2 , wherein an average grain size of the matrix phase is 1 to 10 μm.

9. The magnesium alloy according to claim 2 , having, in the values measured according to JIS Z2241, a tensile strength of 230 to 380 MPa, a proof stress of 180 to 330 MPa, a fracture elongation of 10 to 30%.

10. A medical device including a metal member comprising the magnesium alloy according to claim 2 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2019
From: UEDA, HIRONORI; INOUE, MASASHI; SASAKI, MAKOTO
To: FUJI LIGHT METAL CO., LTD.; JAPAN MEDICAL DEVICE TECHNOLOGY CO., LTD.
Reel/Frame 049702/0264 →
Priority Claims (1)
JP JP2017-001887 · Jan 10, 2017 · national
Continuity (2)
Continuation PCTJP2017046768 · Dec 26, 2017
Related Publication 20190330718A1 · Oct 31, 2019